跳至主要内容
临床试验/JPRN-UMIN000010758
JPRN-UMIN000010758已完成4 期

The effect of activated vitamin D on reducing the progression from impaired glucose tolerance (IGT) to type 2 diabetes (Phase IV, multicenter, randomized, double blind, placebo controlled, and parallel group comparison) - DPVD (Diabetes Prevention with Vitamin D) trial (Phase IV, multicenter, randomized, double blind, placebo controlled, and parallel group comparison)

Kokura Medical Association Health Testing and Services Center0 个研究点目标入组 1,250 人开始时间: 2013年5月20日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Participants are ineligible if they meet any of the following criteria: have a history of diabetes; participate in other investigational trials; have a history of taking anti-diabetic drugs, other activated vitamin D, or bisphosphonates within past three months; are pregnant; have coronary, peripheral, or cerebrovascular disease; or have some types of a severe disease (e.g., renal insufficiency, hepatic insufficiency, terminal disease).

研究者

发起方
Kokura Medical Association Health Testing and Services Center

相似试验

The effect of activated vitamin D on reducing the... | 临床试验